Screener
Natera, Inc. NTRA Accrued charges for third-party testing
Accrued charges for third-party testing at other companies
Other financials
Where this comes from
Reported directly by Natera, Inc. in its filing.
Tagged under the XBRL concept ntra:AccruedChargesForOutsourcedTesting.
The source filing: Natera, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054525
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Clinical trials and studies | 28,442 | 14,467 |
| Marketing and corporate affairs | 26,242 | 20,215 |
| Property and equipment purchases | 20,458 | 11,270 |
| Accrued charges for third-party testing | 18,427 | 20,874 |
| Operating lease liabilities, current portion | 15,123 | 15,581 |
| Accrued third-party service fees | 10,287 | 9,758 |
| Reserves for refunds to insurance carriers | 9,662 | 9,507 |
| Sales and income tax payable | 9,350 | 8,365 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Natera, Inc.'s accrued charges for third-party testing?
- Natera, Inc. (NTRA) reported accrued charges for third-party testing of $18.43M in Q2 2026.
- What does accrued charges for third-party testing mean?
- Accrued charges for third-party testing as reported by Natera, Inc. Common Stock.
Ask your AI about Natera, Inc.'s accrued charges for third-party testing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude